{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:37:21Z","timestamp":1788262641510,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00405-025-09983-9","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:23:12Z","timestamp":1769016192000},"page":"1787-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Short-term effectiveness of tezepelumab on ENT manifestations in patients undergoing treatment for severe asthma: A pilot real-life study"],"prefix":"10.1007","volume":"283","author":[{"given":"Elena","family":"Cantone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Manganello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Detoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Patella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-6128","authenticated-orcid":false,"given":"Teodoro","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Brandon","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"9983_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4168\/aair.2020.12.2.176","volume":"12","author":"Z Liu","year":"2020","unstructured":"Liu Z, Chen J, Cheng L, Li H, Liu S, Lou H, Shi J, Sun Y, Wang D, Wang C, Wang X, Wei Y, Wen W, Yang P, Yang Q, Zhang G, Zhang Y, Zhao C, Zhu D, Zhu L, Chen F, Dong Y, Fu Q, Li J, Li Y, Liu C, Liu F, Lu M, Meng Y, Sha J, She W, Shi L, Wang K, Xue J, Yang L, Yin M, Zhang L, Zheng M, Zhou B, Zhang L (2020) Chinese society of allergy and Chinese society of otorhinolaryngology-head and neck surgery guideline for chronic rhinosinusitis. Allergy Asthma Immunol Res 12:176\u2013237","journal-title":"Allergy Asthma Immunol Res"},{"key":"9983_CR2","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I et al (2020) European position paper on rhinosinusitis and nasal polyps vol 58. Rhinology, p 464","DOI":"10.4193\/Rhin20.601"},{"issue":"2","key":"9983_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.anl.2023.08.005","volume":"51","author":"K Mitsuhiro Okano","year":"2024","unstructured":"Mitsuhiro Okano K, Kanai A, Oka (2024) Pathogenesis-based application of biologics for chronic rhinosinusitis: current and future perspectives. Auris Nasus Larynx 51(2):371\u2013378","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"9983_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11882-024-01186-2","volume":"25","author":"E De Corso","year":"2024","unstructured":"De Corso E, Hellings PW, Wytske J, Fokkens L, Klimek, Anju T, Peters GK, Scadding M, Desrosiers SE, Lee (2024) Joaquim Mullol. Thymic stromal lymphopoietin (TSLP): evidence in respiratory Epithelial-driven diseases including chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep 25(1):7","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"9983_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241246740","volume":"52","author":"F Menzella","year":"2024","unstructured":"Menzella F, Munari S, Corsi L, Tonin S, Cestaro W, Ballarin A, Floriani A, Dartora C, Senna G (2024) Tezepelumab: patient selection and place in therapy in severe asthma. J Int Med Res 52(4):3000605241246740","journal-title":"J Int Med Res"},{"issue":"18","key":"9983_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186878","volume":"21","author":"E Chiarella","year":"2020","unstructured":"Chiarella E, Lombardo N, Lobello N, Aloisio A, Aragona T, Pelaia C, Scicchitano S, Bond HM, Mesuraca M (2020) Nasal polyposis: insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells. Int J Mol Sci 21(18):6878. https:\/\/doi.org\/10.3390\/ijms21186878","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9983_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11882-024-01135-z","volume":"24","author":"E De Corso","year":"2024","unstructured":"De Corso E, Pipolo C, Caminati M, Cantone E, Seccia V, Cecchi L, Nettis E, Garzaro M, Ottaviano G, Gelardi M, Cavaliere C, Heffler E, Pagella F, Pasquini E, Trimarchi M, Gallo S, La Mantia I, Torretta S, Mattavelli D, Caruso C, Matucci A, Vultaggio A, Bellocchi G, Alicandri Ciufelli M, Fm P, Senna G (2024) Multidisciplinary Decision-Making-ITAlian consensus after two years of real practice on the management of severe uncontrolled CRSwNP by biologics (ITACA Study). Curr Allergy Asthma Rep 24(3):143\u2013154","journal-title":"Curr Allergy Asthma Rep"},{"issue":"11","key":"9983_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/jpm14111112","volume":"14","author":"E Cantone","year":"2024","unstructured":"Cantone E, Cassiano B, Pezzella P, Russo MB, Detoraki A (2024) Path2 Federico II task force. The effects of mepolizumab on crswnp: real-life evidence. J Pers Med 14(11):1112","journal-title":"J Pers Med"},{"key":"9983_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-017-0157-8","volume":"7","author":"G De Greve","year":"2017","unstructured":"De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF (2017) Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy 7:22. https:\/\/doi.org\/10.1186\/s13601-017-0157-8","journal-title":"Clin Transl Allergy"},{"key":"9983_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/all.15134","volume":"77","author":"RJL van der Lans","year":"2022","unstructured":"van der Lans RJL, Fokkens WJ, Adriaensen GFJPM, Hoven DR, Drubbel JJ, Reitsma S (2022) Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy 77:670\u20134. https:\/\/doi.org\/10.1111\/all.15134","journal-title":"Allergy"},{"issue":"3","key":"9983_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","volume":"149","author":"P Gevaert","year":"2022","unstructured":"Gevaert P, Saenz R, Corren J, Han JK, Mullol J, Lee SE et al (2022) Long-term efficacy and safety of Omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol 149(3):957\u201365e3","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9983_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/alr.23219","volume":"14","author":"M Desrosiers","year":"2023","unstructured":"Desrosiers M, Diamant Z, Castelnuovo P, Hellings PW, Han JK, Peters AT et al (2023) Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up. Int Forum Allergy Rhinol 14(1):18\u201331","journal-title":"Int Forum Allergy Rhinol"},{"key":"9983_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","volume":"9","author":"JK Han","year":"2021","unstructured":"Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW et al (2021) Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): A randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 9:1141\u20131153","journal-title":"Lancet Respir Med"},{"key":"9983_CR14","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V et al (2023) Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL). Allergy 78:2669\u20132683. https:\/\/doi.org\/10.1111\/all.15772","journal-title":"Allergy"},{"issue":"9","key":"9983_CR15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00011-024-01908-2","volume":"73","author":"S Yan","year":"2024","unstructured":"Yan S, Yang B, Qin H, Du C, Liu H, Jin T (2024) Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management. Inflamm Res 73(9):1425\u20131434. https:\/\/doi.org\/10.1007\/s00011-024-01908-2","journal-title":"Inflamm Res"},{"key":"9983_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/JAA.S4130","volume":"16","author":"TM Laidlaw","year":"2023","unstructured":"Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E et al (2023) Tezepelumab efficacy in patients with Severe, uncontrolled asthma with comorbid nasal polyps in NAVIGATOR. JAA 16:915\u2013932. https:\/\/doi.org\/10.2147\/JAA.S4130","journal-title":"JAA"},{"key":"9983_CR17","doi-asserted-by":"publisher","unstructured":"Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, Pfaar O, Li T, Chen C, Almqvist G, Margolis MK, McLaren J, Jagadeesh S, MacKay J, Megally A, Hellqvist \u00c5, Mankad VS, Bahadori L, Ponnarambil SS (2025) WAYPOINT Study Investigators. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med. 392(12):1178\u20131188. https:\/\/doi.org\/10.1056\/NEJMoa2414482.","DOI":"10.1056\/NEJMoa2414482"},{"key":"9983_CR18","unstructured":"The global asthma report 2018 (2018) Global Asthma Network. [2024-12-09]. https:\/\/globalasthmareport.org\/2018\/index.html"},{"key":"9983_CR19","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","volume":"117","author":"VJ Lund","year":"1997","unstructured":"Lund VJ, Kennedy DW (1997) Staging for rhinosinusitis. Otolaryngol Head Neck Surg 117:S35\u2013S40","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9983_CR20","doi-asserted-by":"publisher","unstructured":"Thwin M, Weitzel EK, McMains KC, Athanasiadis T, Psaltis A, Field J, Wormald PJ (2009) Validating the use of report-derived Lund-MacKay scores. Am J Rhinol Allergy. 23(1):33\u2009\u2013\u20095 https:\/\/doi.org\/10.2500\/ajra.2009.23.3255.\u00a0","DOI":"10.2500\/ajra.2009.23.3255"},{"key":"9983_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.14639\/0392-100X-N0364","volume":"40","author":"S Gallo","year":"2020","unstructured":"Gallo S, Russo F, Mozzanica F, Preti A, Bandi F, Costantino C, Gera R, Ottaviani F, Castelnuovo P (2020) Prognostic value of the sinonasal outcome test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol Ital 40:113\u2013121","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9983_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020485","volume":"11","author":"MS Dom\u00ednguez-Sosa","year":"2023","unstructured":"Dom\u00ednguez-Sosa MS, Cabrera-Ram\u00edrez MS, Marrero-Ramos MdC, D\u00e1vila-Quintana D, Cabrera-L\u00f3pez C, Carrillo-D\u00edaz T, del Rosario JJB (2023) Real-life effectiveness of mepolizumab in refractory chronic rhinosinusitis with nasal polyps. Biomedicines 11:485. https:\/\/doi.org\/10.3390\/biomedicines11020485","journal-title":"Biomedicines"},{"key":"9983_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12081215","volume":"12","author":"E Cantone","year":"2022","unstructured":"Cantone E, De Corso E, Ricciardiello F, Di Nola C, Grimaldi G, Allocca V, Motta G (2022) Olfaction recovery following dupilumab is independent of nasal polyp reduction in CRSwNP. J Pers Med 12:1215. https:\/\/doi.org\/10.3390\/jpm12081215","journal-title":"J Pers Med"},{"key":"9983_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino16.248","volume":"54","author":"T Hummel","year":"2017","unstructured":"Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, Damm M, Frasnelli J, Gudziol H, Gupta N et al (2017) Position paper on olfactory dysfunction. Rhinol Suppl 54:1\u201330","journal-title":"Rhinol Suppl"},{"key":"9983_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","volume":"113","author":"RA Nathan","year":"2004","unstructured":"Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Pendergraft TB (2004) Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113:59\u201365","journal-title":"J Allergy Clin Immunol"},{"key":"9983_CR26","doi-asserted-by":"crossref","unstructured":"Fujieda S, Wang C, Yoshikawa M, Asako M, Suzaki I, Bachert C, Han JK, Fuller A, Baylis L, Su L, Sasaki E, Sousa AR, Chan R, Zhang L (2024) Mepolizumab in CRSwNP\/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia Rhinology. 62(5):576\u2013589","DOI":"10.4193\/Rhin24.156"},{"key":"9983_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM et al (2017) Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377:936\u2013946. https:\/\/doi.org\/10.1056\/NEJMoa1704064","journal-title":"N Engl J Med"},{"key":"9983_CR28","doi-asserted-by":"publisher","unstructured":"Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B et al (2023) Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials. Am J Respir Crit Care Med. 208:13\u201324. https:\/\/doi.org\/10.1164\/rccm.202210-2005OC","DOI":"10.1164\/rccm.202210-2005OC"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09983-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:51:47Z","timestamp":1773971507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09983-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9983"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09983-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author Cantone E. declares having potential conflicts of interest as they have collaborated over the years with the following industries: SANOFI, GSK, NOOS, Sakura, DMG and Astra Zeneca.The authors Pezzella P., Manganello G., D\u2019amato M., Detoraki A., Calabrese C., Patella P., Aragona T. and Russo M.B. declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}